Article
31 Oct 2022
Crocs Successfully Asserts Industrial Design, Awarded Infringer's Profits
AUTHORS CONTENT
Article
15 Jun 2022
Promise Me No Promises? The Five-year Anniversary Of The Supreme Court's AstraZeneca Decision
Article
30 Dec 2021
Amendments To The Patented Medicines Regulations Delayed Six Months, Until July 1, 2022
Article
22 Oct 2021
Strike Three: Federal Court Finds That Health Canada Failed To Consider Context And Purpose Of The CSP Regime
Article
15 Oct 2021
Patent Applications - Consider Requesting Examination Now To Avoid Proposed Excess Claim Fees
Article
23 Jul 2021
Proposed Amendments To Canadian Patent Rules Introduce "Excess" Claim Fees And Limit Number Of Office Actions
Article
01 Jul 2021
Amendments To The Patented Medicines Regulations Delayed By A Further Six Months, Until January 1, 2022
Article
06 May 2021
PMPRB Seeks Feedback On Guideline Monitoring And Evaluation Plan
Article
29 Apr 2021
Proposed Amendments To Listing Patents On Canada's Patent Register
Article
22 Apr 2021
Federal Court Of Appeal Defers To Health Canada On Interpretation Of Csp Regulations
Article
15 Mar 2021
Takeda Successfully Defends Canadian VYVANSE® Patent On Appeal
Article
04 Jan 2021
Amendments To The Patented Medicines Regulations Delayed By 6-months, Until July 1, 2021
Article
29 Jul 2020
Strike 2: Health Canada's Narrow Interpretation Of The CSP Regulations Rejected Once Again
Article
03 Apr 2020
COVID-19 Emergency Response Act: Amendments To The Patent Act
Article
06 Jun 2019
Sports And Recreation: Risk Mitigation And Occupiers' Liability
Article
08 Nov 2018
A First Reading Of Bill C-86 Introduces A Number Of Amendments To The Patent Act, Copyright Act And Trademarks Act
Article
09 Oct 2018
The USMCA: What Does It Mean For Patents And The Pharmaceutical Industry?